ATE221084T1 - Neuer megakaryocyten-verstärker - Google Patents

Neuer megakaryocyten-verstärker

Info

Publication number
ATE221084T1
ATE221084T1 AT93900384T AT93900384T ATE221084T1 AT E221084 T1 ATE221084 T1 AT E221084T1 AT 93900384 T AT93900384 T AT 93900384T AT 93900384 T AT93900384 T AT 93900384T AT E221084 T1 ATE221084 T1 AT E221084T1
Authority
AT
Austria
Prior art keywords
amplifier
megakaryocyte
meg
pot
new
Prior art date
Application number
AT93900384T
Other languages
German (de)
English (en)
Inventor
Nozomi - Shinmitamag Yamaguchi
Kuramaguch Teramachinishihairu
Masayoshi Chugai Seiyak Oh-Eda
Kunihiro Chugai Seiyak Hattori
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE221084T1 publication Critical patent/ATE221084T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4705Regulators; Modulating activity stimulating, promoting or activating activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Amplifiers (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT93900384T 1991-12-27 1992-12-24 Neuer megakaryocyten-verstärker ATE221084T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP36152291 1991-12-27
JP12251892 1992-03-31
PCT/JP1992/001689 WO1993013132A1 (fr) 1991-12-27 1992-12-24 Nouvel amplificateur de megakaryocytes

Publications (1)

Publication Number Publication Date
ATE221084T1 true ATE221084T1 (de) 2002-08-15

Family

ID=26459624

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93900384T ATE221084T1 (de) 1991-12-27 1992-12-24 Neuer megakaryocyten-verstärker

Country Status (12)

Country Link
US (1) US5498698A (ref)
EP (1) EP0621285B1 (ref)
JP (1) JP3328341B2 (ref)
KR (1) KR100233701B1 (ref)
CN (1) CN1075148A (ref)
AT (1) ATE221084T1 (ref)
AU (1) AU658040B2 (ref)
CA (1) CA2126680C (ref)
DE (1) DE69232698T2 (ref)
ES (1) ES2180542T3 (ref)
TW (1) TW224975B (ref)
WO (1) WO1993013132A1 (ref)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL107366A (en) * 1992-10-23 2003-03-12 Chugai Pharmaceutical Co Ltd Genes coding for megakaryocyte potentiator
DE69503849T2 (de) * 1994-03-31 1999-04-01 Amgen Inc., Thousand Oaks, Calif. Zusammensetzungen und Verfahren zur Anregung des Wachstums und der Differenzierung von Megakaryozyten
US5795569A (en) * 1994-03-31 1998-08-18 Amgen Inc. Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation
US7375183B1 (en) * 1996-01-05 2008-05-20 The United States Of America As Represented By The Department Of Health And Human Services Mesothelin, immunogenic peptides derived therefrom, and compositions comprising mesothelin, or immunogenic peptides thereof
JP2000505787A (ja) * 1996-01-05 2000-05-16 アメリカ合衆国 中皮抗原及びそれを標的化するための方法及びキット
US6809184B1 (en) * 1997-12-01 2004-10-26 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Antibodies, including FV molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use
US6589759B1 (en) 1999-03-30 2003-07-08 Trustees Of Boston University Compositions and methods for producing platelets and/or proplatelets from megakaryocytes
DE60039510D1 (de) 1999-05-27 2008-08-28 Us Gov Health & Human Serv Immunokonjugate mit hoher bindungsaffinität
US9200036B2 (en) 2002-07-12 2015-12-01 The Johns Hopkins University Mesothelin vaccines and model systems
AU2003259109A1 (en) * 2002-07-12 2004-02-02 The Johns Hopkins University Mesothelin vaccines and model systems
US20090110702A1 (en) * 2002-07-12 2009-04-30 The Johns Hopkins University Mesothelin Vaccines and Model Systems and Control of Tumors
US20040180387A1 (en) * 2003-03-13 2004-09-16 Fujirebio Diagnostics, Inc. Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of ovarian cancer
SI2195017T1 (sl) 2007-10-01 2015-01-30 Bristol-Myers Squibb Company Človeška protitelesa, ki vežejo mezotelin in njihova uporaba

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU646530B2 (en) * 1990-12-28 1994-02-24 Asahi Kasei Kogyo Kabushiki Kaisha Novel megakaryocyte amplifier and production thereof
JPH04295500A (ja) * 1991-03-26 1992-10-20 Asahi Chem Ind Co Ltd 新規な巨核球増幅因子とその製法

Also Published As

Publication number Publication date
CA2126680C (en) 2002-10-08
JPH05331200A (ja) 1993-12-14
WO1993013132A1 (fr) 1993-07-08
EP0621285A4 (en) 1995-05-24
EP0621285B1 (en) 2002-07-24
ES2180542T3 (es) 2003-02-16
KR100233701B1 (ko) 1999-12-01
AU658040B2 (en) 1995-03-30
CA2126680A1 (en) 1993-07-08
DE69232698T2 (de) 2003-03-20
KR940703858A (ko) 1994-12-12
US5498698A (en) 1996-03-12
AU3172193A (en) 1993-07-28
EP0621285A1 (en) 1994-10-26
JP3328341B2 (ja) 2002-09-24
DE69232698D1 (de) 2002-08-29
CN1075148A (zh) 1993-08-11
TW224975B (ref) 1994-06-11

Similar Documents

Publication Publication Date Title
DE69232698D1 (de) Neuer megakaryocyten-verstärker
ATE238345T1 (de) Protegrine
ATE209215T1 (de) Protegrine
DE59007517D1 (de) Neue proteine mit tnf-hemmender wirkung und ihre herstellung.
ATE219103T1 (de) Cnp-analoge peptide und ihre verwendung
DK0656945T3 (da) Stressproteinepitoper
ATE171712T1 (de) Neuartiger menschlicher proteaseinhibitor vom kunitz-typ und entsprechende varianten
EP0662516A4 (en) NEW ELAFINE DERIVATIVE.
DE69018926D1 (de) Vakzine gegen Bordetella.
EP0796867A4 (en) Peptide, bronchodilator and blood flow ameliorant
DE68910382D1 (de) Oxabicycloalkan-ether als Herbizide.
DK1005487T3 (da) Ydre 74 kD-membranprotein fra Moraxella catarrhalis
ES2103792T3 (es) Factor de crecimiento de union a la heparina.
ATE116336T1 (de) Bakteriozin-peptid.
DK0424670T3 (da) Nye CNS-aktive hexapeptider med antiamnestisk virkning
SE8904188D0 (sv) Chromogenic substrate
SE9101586D0 (sv) Modified thioredoxin and its use
ATE119779T1 (de) Verwendung von 5'-vinylhalo- aristeromycin/adenosin-analoga als immunsuppressiva.
ECSP972344A (es) Proteinas antiobesidad